129 related articles for article (PubMed ID: 38824646)
41. Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis.
Maloberti A; Riva M; Tadic M; Valena C; Villa P; Boggioni I; Pozzi MR; Grassi G
High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):97-104. PubMed ID: 29330703
[TBL] [Abstract][Full Text] [Related]
42. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies.
Angel K; Provan SA; Hammer HB; Mowinckel P; Kvien TK; Atar D
Fundam Clin Pharmacol; 2011 Aug; 25(4):511-7. PubMed ID: 20825487
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study.
Baghdadi LR; Woodman RJ; Shanahan EM; Wiese MD; Mangoni AA
Pharmgenomics Pers Med; 2018; 11():205-210. PubMed ID: 30519074
[TBL] [Abstract][Full Text] [Related]
44. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
[TBL] [Abstract][Full Text] [Related]
45. Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors.
Crilly MA; Kumar V; Clark HJ; Scott NW; Macdonald AG; Williams DJ
Rheumatology (Oxford); 2009 Dec; 48(12):1606-12. PubMed ID: 19858120
[TBL] [Abstract][Full Text] [Related]
46. Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients: sex-specific variations.
Elsurer R; Afsar B
Blood Press Monit; 2014 Oct; 19(5):271-9. PubMed ID: 24892881
[TBL] [Abstract][Full Text] [Related]
47. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex.
Gomez-Marcos MA; Recio-Rodríguez JI; Patino-Alonso MC; Agudo-Conde C; Gomez-Sanchez L; Rodriguez-Sanchez E; Gomez-Sanchez M; Martinez-Vizcaino V; Garcia-Ortiz L
BMC Cardiovasc Disord; 2012 Jun; 12():37. PubMed ID: 22676422
[TBL] [Abstract][Full Text] [Related]
48. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
49. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
Van Doornum S; McColl G; Wicks IP
Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
[TBL] [Abstract][Full Text] [Related]
50. Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis.
Botta E; Meroño T; Saucedo C; Martín M; Tetzlaff W; Sorroche P; Boero L; Malah V; Menafra M; Gómez Rosso L; Chapman JM; Kontush A; Soriano E; Brites F
Atherosclerosis; 2016 Aug; 251():438-444. PubMed ID: 27344073
[TBL] [Abstract][Full Text] [Related]
51. Aldosterone glucuronidation inhibition as a potential mechanism for arterial dysfunction associated with chronic celecoxib and diclofenac use in patients with rheumatoid arthritis.
Crilly MA; Mangoni AA; Knights KM
Clin Exp Rheumatol; 2013; 31(5):691-8. PubMed ID: 23899748
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Kim G; Barner JC; Rascati K; Richards K
J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
[TBL] [Abstract][Full Text] [Related]
53. Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors.
Pieringer H; Stuby U; Pohanka E; Biesenbach G
Rheumatol Int; 2010 Aug; 30(10):1335-9. PubMed ID: 19823841
[TBL] [Abstract][Full Text] [Related]
54. Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study.
Mangoni AA; Baghdadi LR; Shanahan EM; Wiese MD; Tommasi S; Elliot D; Woodman RJ
Ther Adv Musculoskelet Dis; 2017 Sep; 9(9):213-229. PubMed ID: 28932292
[TBL] [Abstract][Full Text] [Related]
55. The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR database.
Dey M; Zhao SS; Moots RJ; Bergstra SA; Landewe RB; Goodson NJ
Rheumatology (Oxford); 2022 Feb; 61(2):713-722. PubMed ID: 33930113
[TBL] [Abstract][Full Text] [Related]
56. Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Ikdahl E; Rollefstad S; Wibetoe G; Olsen IC; Berg IJ; Hisdal J; Uhlig T; Haugeberg G; Kvien TK; Provan SA; Semb AG
J Rheumatol; 2016 Sep; 43(9):1622-30. PubMed ID: 27307523
[TBL] [Abstract][Full Text] [Related]
57. The major determinants of arterial stiffness in Korean patients with rheumatoid arthritis are age and systolic blood pressure, not disease-related factors.
Kim YS; Sung YK; Choi CB; Uhm WS; Kim TH; Shin JH; Jun JB
Rheumatol Int; 2012 Nov; 32(11):3455-61. PubMed ID: 22057143
[TBL] [Abstract][Full Text] [Related]
58. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
[TBL] [Abstract][Full Text] [Related]
59. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
[TBL] [Abstract][Full Text] [Related]
60. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
Boytsov NN; Bhattacharya R; Saverno K; Dixon L; Abbott PL; Zhang X; Gaich CL; Nair R
J Manag Care Spec Pharm; 2019 Aug; 25(8):879-887. PubMed ID: 31347977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
